CellVive NMN™ (β-Nicotinamide Mononucleotide) is a trademarked longevity ingredient positioned to become the benchmark standard for NAD⁺ restoration in Australia and beyond.

Consumer demand for NMN is rapidly growing, driven by increasing awareness of its role in restoring NAD⁺ levels and supporting healthy ageing and longevity. Backed by promising scientific research, NMN is emerging as a sought-after longevity supplement for those looking to enhance energy, cognition, immunity, and overall vitality. A systemic decline in the levels of NAD⁺ across various tissues is associated with all the hallmarks of ageing.

NMN is backed by more than 150 studies published across various databases, e.g., PubMed, ScienceDirect, Cochrane, EFSA, and Health Canada, among others.

Research on NMN suggests that it plays a significant role in enhancing cellular function and promoting overall health. Studies indicate that NMN may improve energy metabolism and support various biological processes, potentially contributing to longevity and better age-related health outcomes.

Research on NMN indicates that it:

• Leads to a rapid increase in NAD⁺ levels
• Activates and regulates metabolic processes
• Enhances cellular energy
• Improves cardiometabolic health, glucose metabolism, and insulin metabolism
• Regulates and enhances immune responses
• Reduces inflammation and oxidative stress
• Activates sirtuins: NAD⁺-dependent enzymes involved in DNA repair, mitochondrial biogenesis, and inflammation regulation

Additionally, NMN contributes to aerobic capacity, improved brain, cognitive, and cardiometabolic health while also facilitating gene expression and cellular stress responses.

Why choose CellVive NMN™

CellVive NMN™ delivers a high-quality, premium NMN product by adhering strictly to TGA regulations, Good Manufacturing Practice (GMP), and the Pharmaceutical Inspection Co-operation Scheme (PIC/S) guidelines. This commitment ensures not only exceptional quality but also transparency throughout the manufacturing process.

CellVive NMN™ is manufactured to rigorous pharmaceutical standards and is supported by comprehensive and documented quality testing. This ensures that consumers receive a safe, effective NMN supplement with reliable dosing, and the assurance and confidence of local regulatory oversight.

Furthermore, we have partnered with various Australian universities to conduct research on CellVive NMN™ through human clinical trials and in-vitro studies, thereby gaining a competitive edge in the field.

TGA Permitted Indications

• Helps enhance NAD⁺ levels in the body
• Maintain/support energy production
• Maintain/support nervous system function
• Maintain/support nervous system health
• Maintain/support skin health
• Antioxidant/Reduce free radicals formed in the body
• Maintain/support general health and wellbeing

Notes

Adults only. Not recommended for children, pregnant or breastfeeding individuals.

For information purposes only. Not a substitute for medical advice. If symptoms persist, talk to a health professional. Always read the label. Follow the directions for use.

References

1. Deng H, et al. Nicotinamide Mononucleotide: Research Process in Cardiovascular Diseases. Int J Mol Sci. 2024 Sep 2;25(17):9526.
2. Liao B, et al. Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: a randomized, double-blind study. J Int Soc Sports Nutr. 2021 Jul 8;18(1):54.
3. Morifuji M, et al. Ingestion of β-nicotinamide mononucleotide increased blood NAD levels, maintained walking speed, and improved sleep quality in older adults in a double-blind randomized, placebo-controlled study. Geroscience. 2024 Oct;46(5):4671-4688.
4. Rahman SU, et al. Role and Potential Mechanisms of Nicotinamide Mononucleotide in Aging. Aging Dis. 2024 Apr 1;15(2):565-583.
5. Soma M, Lalam SK. The role of nicotinamide mononucleotide (NMN) in anti-aging, longevity, and its potential for treating chronic conditions. Mol Biol Rep. 2022 Oct;49(10):9737-9748.
6. Song Q, et al. The Safety and Antiaging Effects of Nicotinamide Mononucleotide in Human Clinical Trials: an Update. Adv Nutr. 2023 Nov;14(6):1416-1435.
7. Wei Z, et al. Nicotinamide mononucleotide: An emerging nutraceutical against cardiac aging? Curr Opin Pharmacol. 2021 Oct;60:291-297.